Aytu BioPharma Ranked Number 178 Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 50(TM)Accesswire • 11/17/21
Aytu Biopharma, Inc. (AYTU) CEO Josh Disbrow on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Aytu BioPharma to Report First Quarter Fiscal 2022 Results and Provide Business Update on November 15, 2021Accesswire • 11/08/21
Aytu BioPharma Inc. (AYTU) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 11/04/21
ALERT: Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by the Aytu BioPharma, Inc. Board of DirectorsPRNewsWire • 10/04/21
CORRECTION: Aytu BioPharma to Present at Upcoming September Investor ConferencesAccesswire • 09/30/21
Aytu Biopharma, Inc.'s (AYTU) CEO Josh Disbrow on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 09/27/21
Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial ResultsAccesswire • 09/27/21
Aytu BioPharma to Report Fourth Quarter and Full Year Fiscal 2021 Results and Provide Business Update on September 27, 2021Accesswire • 09/23/21
Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with CoronavirusAccesswire • 07/27/21
Implied Volatility Surging for Aytu Biopharma (AYTU) Stock OptionsZacks Investment Research • 07/07/21
Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot StudyAccesswire • 06/28/21
Aytu Biopharma, Inc. (AYTU) CEO Joshua Disbrow on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/18/21
Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business HighlightsAccesswire • 05/17/21
Aytu BioPharma Announces Publication of In Vitro Study Demonstrating That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within CellsAccesswire • 05/12/21
Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus TherapeuticsAccesswire • 04/12/21